CLC604 preferentially inhibits the growth of HER2-overexpressing cancer cells and sensitizes these cells to the inhibitory effect of Taxol in vitro and in vivo

Author:                    

Publisher: Spandidos Publications

ISSN: 1021-335X

Source: Oncology Reports, Vol.30, Iss.4, 2013-01, pp. : 1762-1772

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next